BIOMARIN PHARMACEUTICAL INC - NOTE 1.250% 5/1

Historical Holders from Q2 2021 to Q3 2025

Type / Class
Debt / NOTE 1.250% 5/1
Market price (% of par)
95.0%
All holders as of 30 Sep 2025
Q3 2025
Total 13F principal as of 30 Sep 2025
$547,434,225
Total reported market value
$521,865,010
Principal change
+$31,836,711
Market value change
+$30,970,903
Number of holders
58
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
70 filings reported holding 09061GAK7 - BIOMARIN PHARMACEUTICAL INC - NOTE 1.250% 5/1.
BIOMARIN PHARMACEUTICAL INC - NOTE 1.250% 5/1 has 58 institutional bondholders. These institutions hold $547,434,225 principal (par value) of the bond.

Institutional Holders of BIOMARIN PHARMACEUTICAL INC - NOTE 1.250% 5/1 across Reporting Periods

Period Principal Value Change Price (% of par) Investors
2025 Q3 $547,434,225 $521,865,010 +$30,970,903 95% 58
2025 Q2 $537,501,514 $507,973,851 +$81,756,015 94.13% 66
2025 Q1 $446,615,880 $421,992,836 -$3,974,640 94.39% 63
2024 Q4 $434,189,749 $403,988,210 +$16,728,324 92.8% 71
2024 Q3 $410,986,406 $391,760,463 -$28,564,977 95.06% 61
2024 Q2 $441,880,177 $423,836,043 -$26,274,760 95.66% 57
2024 Q1 $467,435,000 $463,851,707 +$11,259,006 99.06% 56
2023 Q4 $460,780,303 $474,919,727 +$15,228,829 102.69% 56
2023 Q3 $446,064,779 $443,342,534 +$475,537 99.08% 48
2023 Q2 $446,081,200 $450,395,136 +$30,175,858 100.86% 48
2023 Q1 $416,185,033 $434,808,012 +$21,703,092 104.3% 45
2022 Q4 $378,710,174 $408,842,645 -$98,743,328 107.58% 44
2022 Q3 $339,484,035 $338,737,224 +$18,727,378 100% 38
2022 Q2 $320,189,619 $320,118,053 -$3,637,441 100% 35
2022 Q1 $323,841,062 $326,316,486 +$104,678,749 100.22% 29
2021 Q4 $217,348,919 $227,106,951 -$32,276,030 104.31% 32
2021 Q3 $246,569,715 $248,479,380 +$2,707,713 100.08% 26
2021 Q2 $243,769,000 $245,269,238 +$245,269,238 100.45% 28